We are live on ! Find out more
William Blair & Company

William Blair & Company Portfolio holdings

AUM $34.9B
1-Year Est. Return 18.88%
This Fund
S&P 500
This Quarter Est. Return
+6.68%
1 Year Est. Return
+18.88%
3 Year Est. Return
+73.84%
5 Year Est. Return
+90.13%
10 Year Est. Return
+512.03%
AUM
$14.7B
AUM Growth
+$562M
Cap. Flow
-$182M
Cap. Flow %
-1.24%
Top 10 Hldgs %
20.54%
Holding
1,679
New
173
Increased
492
Reduced
677
Closed
92

Top Buys

Rank Stock Value
1
P
Everpure Inc
P
+$58.5M
2
DOCU
DocuSign
DOCU
+$21.3M
3
BKE icon
Buckle
BKE
+$20.9M
4
MSFT icon
Microsoft
MSFT
+$18.4M
5
USFD icon
US Foods
USFD
+$14.4M

Sector Composition

Rank Sector Weight
1 Technology 20.16%
2 Healthcare 17.99%
3 Financials 13.41%
4 Industrials 9.72%
5 Consumer Discretionary 9.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMC icon
1151
AMC Entertainment Holdings
AMC
$2.39B
$280K ﹤0.01%
+1,763
New +$284K
CNA icon
1152
CNA Financial
CNA
$14.3B
$280K ﹤0.01%
6,124
-202
-3% -$9.76K
CMD
1153
DELISTED
Cantel Medical Corporation
CMD
$279K ﹤0.01%
2,832
-453
-14% -$50.7K
FMC icon
1154
FMC
FMC
$1.32B
$277K ﹤0.01%
3,585
+447
+14% +$33.2K
TT icon
1155
Trane Technologies
TT
$104B
$275K ﹤0.01%
3,060
+307
+11% +$27K
A icon
1156
Agilent Technologies
A
$39.3B
$274K ﹤0.01%
4,435
+415
+10% +$27.1K
AGCO icon
1157
AGCO
AGCO
$7.51B
$274K ﹤0.01%
4,519
-630
-12% -$40.2K
FANG icon
1158
Diamondback Energy
FANG
$54B
$274K ﹤0.01%
+2,083
New +$258K
ALXN
1159
DELISTED
Alexion Pharmaceuticals
ALXN
$274K ﹤0.01%
2,206
-655
-23% -$76.5K
CSQ icon
1160
Calamos Strategic Total Return Fund
CSQ
$3.33B
$272K ﹤0.01%
+21,503
New +$265K
PLD icon
1161
Prologis
PLD
$130B
$272K ﹤0.01%
4,148
+149
+4% +$9.58K
AZZ icon
1162
AZZ Inc
AZZ
$4.59B
$271K ﹤0.01%
6,235
HGV icon
1163
Hilton Grand Vacations
HGV
$3.59B
$271K ﹤0.01%
7,801
+1,672
+27% +$67.7K
ARCH
1164
DELISTED
Arch Resources, Inc.
ARCH
$271K ﹤0.01%
+3,450
New +$294K
RQI icon
1165
Cohen & Steers Quality Income Realty Fund
RQI
$1.7B
$268K ﹤0.01%
+22,304
New +$260K
AEF
1166
abrdn Emerging Markets Equity Income Fund
AEF
$373M
$266K ﹤0.01%
+38,064
New +$327K
IYK icon
1167
iShares US Consumer Staples ETF
IYK
$1.41B
$266K ﹤0.01%
6,759
SIRI icon
1168
SiriusXM
SIRI
$10.4B
$266K ﹤0.01%
3,924
-220
-5% -$14.9K
GEN icon
1169
Gen Digital
GEN
$16.9B
$265K ﹤0.01%
12,816
+1,901
+17% +$45.7K
PACW
1170
DELISTED
PacWest Bancorp
PACW
$265K ﹤0.01%
5,361
+624
+13% +$32.6K
MOS icon
1171
The Mosaic Company
MOS
$7.22B
$264K ﹤0.01%
9,416
+15
+0.2% +$407
TCRT icon
1172
Alaunos Therapeutics
TCRT
$4.64M
$263K ﹤0.01%
+581
New +$368K
ASB icon
1173
Associated Banc-Corp
ASB
$5.99B
$262K ﹤0.01%
9,582
FEI
1174
DELISTED
FIRST TRUST MLP AND ENERGY INCOME FUND
FEI
$261K ﹤0.01%
+20,000
New +$255K
CPRI icon
1175
Capri Holdings
CPRI
$1.9B
$260K ﹤0.01%
3,911
-98
-2% -$6.4K

Similar funds

William Blair & Company's Q2 2018 Portfolio in Review

As of Q2 2018, William Blair & Company held 1,679 positions worth $14.7B, up 4% from $14.1B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

William Blair & Company's Q2 2018 filing shows 173 new, 492 increased, 677 reduced and 92 closed positions. Its largest new stake was DocuSign: 422,114 shares worth $22.4M. The largest sale was Starbucks, an estimated $47M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

  • William Blair & Company's largest Q2 2018 buy was DocuSign: 422,114 shares worth $22.4M.
  • William Blair & Company added most to Everpure Inc in Q2 2018, an estimated $58.5M increase.
  • William Blair & Company's biggest Q2 2018 reduction was Starbucks, cutting an estimated $47M.
  • William Blair & Company fully exited Cavium, Inc. in Q2 2018, selling an estimated $9.64M.
  • William Blair & Company's ten largest holdings make up 21% of its $14.7B portfolio in Q2 2018.
  • William Blair & Company opened 173 new positions and closed 92 in Q2 2018.
  • William Blair & Company's portfolio value rose 4% quarter-over-quarter to $14.7B.

Based on William Blair & Company's 13F filing for Q2 2018, filed 13 Aug 2018.